Canada In-vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Canada In-Vitro Diagnostics Companies and the Market is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, and Other Tests), Product (Instrument, Reagent, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Diseases, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications), and End Users (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users). The Market Values are Provided (in USD) for the Above Segments.

Canada In-vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Canada in-vitro Diagnostics Industry Overview

The Canadian In-Vitro Diagnostics market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. In addition, the rising need for diagnostics due to the rising prevalence of diseases and the advances in IVD is helping a few other smaller players enter the market. Some of the major players in the market are Becton Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, and Thermo Fisher Scientific, among others.

Canada in-vitro Diagnostics Market Leaders

  1. Bio-Rad Laboratories Inc.

  2. Danaher Corporation

  3. Siemens Healthineers

  4. Abbott Laboratories

  5. Becton, Dickinson and Company

  6. *Disclaimer: Major Players sorted in no particular order
CL-CIVDM.png